About Ivo Timmermans | CEO, Pleco Therapeutics
Ivo worked for pharmaceutical and biotech companies for twenty five years, and was involved in the strategic development of medicines and various product launches. He held senior positions like Global Medical Director of Rhein Biotech, and Chief Medical Officer of Clinigen Group Plc. Ivo was CEO of four start-up companies in the Netherlands and non-executive director of Phico Therapeutics in Cambridge, UK. His specialties include oncology, immunology, viral diseases, and vaccines. Ivo holds a medical degree (MD) from the University in Nijmegen (Netherlands) and a Master of Business Administration degree (MBA) from Henley Management College in Henley-on-Thames, UK.
Pleco Therapeutics BV is a Dutch private limited company, established to develop new medicines that generate a break-through improvement in the survival rate of cancer patients. Pleco utilises a global network of academic centres and contract research organisations to develop and test novel combination products for those cases where chemotherapy is not enough. The first products are currently being tested in preclinical models.
| Powered by: Hyphen Projects | Connect | Join Global Investor Forum | |||
| Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 |
|
REGISTER NOW
SUBSCRIBE TO OUR NEWSLETTER
|
© Copyright 2025 by Hyphen Projects